NEW YORK (GenomeWeb) – Qiagen said after the close of the market on Friday that it is transferring the US listing of its global shares to the New York Stock Exchange from the Nasdaq Global Market. The transfer is expected to be effective on or about Jan. 10, 2018. Qiagen's shares will continue to trade on the Nasdaq until the transfer is completed. The company's shares will continue to trade under the ticker "QGEN" after the transfer, and there will be no impact on the trading of Qiagen's global shares on the Frankfurt Stock Exchange under the ticker "QIA."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more